FDA Tiptoes Around BPA
The FDA’s failure to protect newborns and the unborn from BPA recalls the old joke “How many deaths does it take for the FDA to remove a drug from the market?” The answer (not all funny): all too many.
The FDA’s failure to protect newborns and the unborn from BPA recalls the old joke “How many deaths does it take for the FDA to remove a drug from the market?” The answer (not all funny): all too many.
The September 2009 newsletter of the Vitamin D Council weighs the scientific evidence pointing to a connection between the use of statin drugs (prescribed to lower cholesterol) and vitamin D deficiency. Are the drugs most often prescribed in the United States linked to vitamin D deficiency, known to affect up to 77 percent of all Americans?
Last week we highlighted the government’s complete silence about Vitamin D during this flu season, complete silence despite the scientific evidence supporting the use of Vitamin D to prevent or treat flu. Not a word has been said by our health authorities
With hundreds of thousands of seasonal flu-related complications, more than 35,000 deaths from the flu, and countless more from the H1N1 flu expected this season, ANH-USA asks the obvious question: What are the Centers for Disease Control (CDC), the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and Health and Human Services (HHS) doing about it? The answer: Not much!
Bill Faloon, Co-founder of Life Extension Foundation, recently summarized some of the science showing the critical role of Vitamin D in preventing and controlling infections due to the flu. An excerpt from his article in the January 2010 Life Extension Magazine follows:
All children deserve the best protection we can provide, but the government is failing to shield our most vulnerable population — the unborn — from chemicals in the environment.
The Natural Products Association and the Council for Responsible Nutrition respond to an initiative by the U.S. Anti-Doping Agency targeting illegal drug products labeled as dietary supplements.
According to Nielsen Media Research, spending on direct-to-consumer drug ads reached $5 billion in 2008, with every American seeing up to 16 hours of these commercials on television each year. A new study published in the Archives of Internal Medicine warns how direct-to-consumer prescription drug advertising escalates the cost of prescription drugs.
Over the past year, Pulse of Health Freedom has focused on safety concerns regarding bisphenol A (BPA) and the FDA’s puzzling about-face on this issue. In February 2009 the American Association for Health Freedom filed a petition with the FDA, asking that it rule on the practice of giving children BPA in the form of dental sealants and composite fillings. But according to the Journal Sentinel, the FDA requested more time so its scientists could consider hundreds of new studies on the effects of this chemical.
President Obama insists that electronic medical records will help cut healthcare costs, and as part of the February 2009 economic stimulus bill, Congress has offered $19 billion in incentives to adopt them. But Sue Blevins of the Institute for Health Freedom has continually warned that EMRs could endanger privacy and freedom of choice.